Summary
The purpose of the study is to characterize the clinical course of homocystinuria in pediatric and adult patients aged 1 to 65 years under current clinical management practices
Conditions
Homocystinuria Due to CBS Deficiency
Recruitment Status
Recruiting
Eligibility Criteria
Inclusion Criteria:
Patients who are clinically diagnosed with homocystinuria
Male/female patients aged 1 to 65 years
Patients who consented and/or assented
Patients who are willing and able to comply with all study-related procedures.
Exclusion Criteria:
Medically significant postnatal complications or congenital anomalies that are not associated with homocystinuria
Received any experimental therapy for homocystinuria during the 6 months prior to enrollment or expected to receive any such therapy during duration of the study
Gender
All
Min Age
1 Year
Max Age
65 Years
Download Date
January 17, 2023
Principal Investigator
N/A
Primary Contact Information
For more information on this trial, visit clinicaltrials.gov.
Contact
For more information and to contact the study team: